Advertise here
Advertise here
Headlines

LOL: June 11, 2024

The Week in Medicine is a round-up of all the latest happenings in Irish medicine, with a new issue released weekly. The latest issue, dated June 11, 2024, is filled with updates and news from the medical field. Stay informed with the latest developments by reading The Week in Medicine from Irish Medical Times. Source…

Read More

What is Oropouche virus? | Medical News Bulletin

Oropouche virus (OROV) is a single-stranded RNA virus that causes a dengue-like illness called Oropouche fever, primarily in Central and South America and the Caribbean. It is transmitted by the Culicoides paraensis midge, with no known human-to-human transmission. Symptoms include fever, chills, fatigue, nausea, and more, sometimes leading to complications like meningitis. Diagnosing Oropouche virus…

Read More

15% of patients experience antidepressant discontinuation symptoms, which are mostly mild

A study published in The Lancet Psychiatry found that one in three people who stop taking antidepressants experience discontinuation symptoms, while one in six people who discontinue a placebo also experience symptoms. The study included 79 studies with 21,002 patients who discontinued antidepressants or placebo. Certain medications, such as imipramine, paroxetine, and desvenlafaxine or venlafaxine,…

Read More

Global vaccine expert criticizes ‘ineptitude’ of U.S. bird flu response

Seth Berkley, a global health leader, criticized the U.S. response to the avian influenza outbreak among dairy cattle, highlighting failures in surveillance, tracking infections, and vaccine readiness. Berkley’s concerns about the H5N1 bird flu outbreak revolve around the lack of preparedness to handle a potential pandemic. The limited information on infected herds and resistance from…

Read More

Mailed feedback to primary care physicians on antibiotic prescribing for patients aged 65 years and older: pragmatic, factorial randomised controlled trial

The research article by Kevin Schartz et al (BMJ 2024;385:e079329) has undergone changes in the order of author affiliations. This adjustment has been made to accurately reflect the contributions and affiliations of each author involved in the study. The revised order of author affiliations provides a more precise representation of the research team and their…

Read More

Massachusetts reports largest single-year decline in opioid-related overdose deaths in two decades

Massachusetts experienced a 10% drop in opioid-related overdose deaths from 2022 to 2023, the largest decline in two decades, with an expected continuation of this trend in 2024. However, the report highlighted concerning data on overdose deaths when broken down by race and ethnicity. While the rates decreased among white, non-Hispanic males, they increased among…

Read More

A Benefit to Add-On Abemaciclib in Advanced Breast Cancer?

Adding abemaciclib, a CDK-4/6 inhibitor, to a nonsteroidal aromatase inhibitor improved overall survival in postmenopausal women with HR+/HER2− advanced breast cancer, although the results did not reach statistical significance. The MONARCH 3 study involved 493 patients who had not received prior systemic therapy in the advanced setting. Patients receiving abemaciclib had a median overall survival…

Read More

Who Should Be Responsible for Rationing GLP-1s?

GLP-1 drugs are effective for weight loss but face shortages and high costs. Dr. Timothy Law believes doctors should make the call on which patients get access, not insurers. Dr. Melanie Jay disagrees, saying individual providers can’t ensure health equity. Law thinks the responsibility should be on pharmaceutical companies to increase supply and lower prices….

Read More

Government do not have the gumption to confront vested interests in order to meet climate targets

Global warming is accelerating at an unprecedented pace, with rising temperatures putting immense stress on marine life. Despite public concerns, the Irish government supports agriculture practices that contribute to emissions. The focus on economic growth over climate targets is hindering progress in addressing climate change. The flawed measure of progress, GDP, fails to account for…

Read More

Headspace partners with Uwill to expand mental health offerings to students

Uwill, a mental health platform for colleges and students, has partnered with digital mental health company Headspace to expand its Urise wellness offerings. Uwill offers on-demand virtual access to therapists and crisis counseling for students, along with online wellness events through their app. The partnership with Headspace will integrate meditation, yoga, and mindfulness offerings into…

Read More

Neutrophil-to-lymphocyte ratio may aid diagnosis of infectious, idiopathic orbital disease

A study published in Ophthalmic Plastic and Reconstructive Surgery found that the neutrophil-to-lymphocyte ratio (NLR) is lower in patients with idiopathic orbital inflammation compared to those with necrotizing fasciitis or orbital cellulitis. Researchers reviewed cases of adult patients with these conditions presenting acutely to the ED and found that an elevated NLR may indicate infectious…

Read More

Michael Mosley: doctor, writer, and broadcaster

Michael Mosley, a renowned doctor, writer, and broadcaster, passed away on 9 June while vacationing in Greece. He was well-known for his work in television, radio, and bestselling diet books. Mosley had a near-death experience as a baby in Calcutta due to the Asian flu outbreak in 1957. He was sent to England for schooling…

Read More

Antenatal COVID-19 vaccination shown to be safe for pregnant women and their babies

A study published in Obstetrics & Gynecology examined the link between antenatal COVID-19 vaccination and adverse pregnancy outcomes. Pregnancy increases the risk of severe outcomes from SARS-CoV-2 infection, leading to complications like preterm birth and hypertensive disorders. While pregnant women were initially excluded from vaccine trials, mRNA COVID-19 vaccines were found to reduce complications for…

Read More

Newer Therapies Target Different Melasma Components

Melasma is a complex skin condition influenced by genetics, hormones, and other factors. Common treatments include hydroquinone, retinoids, steroids, and triple combination cream. New treatments like azelaic acid, tranexamic acid, cysteamine, malassezin, methimazole, thiamidol, and 2-mercaptonicotinoyl glycine are proving effective. Laser treatments may be used for resistant cases. Education, skin exams, and pretreatment with tinted…

Read More

Ultra-Processed Plant Food Raises Risk Of Heart Diseases, Related Deaths: Study

A recent study published in The Lancet Regional Health—Europe found that consuming ultra-processed plant-based foods is linked to an increased risk of cardiovascular diseases and mortality, despite the health benefits typically associated with plant-based diets. Researchers analyzed data from over 118,000 participants and found that plant-based non-UPFs were associated with better health outcomes, while plant-based…

Read More

Why Is Moon Surgical’s New Commercial Robot System Important?

Moon Surgical, a robotics startup, aims to create an efficient, sustainable, and digitized operating room of the future. They recently received FDA clearance for the commercial version of their Maestro surgical robot system, designed to support soft tissue surgical procedures not currently supported by existing telerobotic systems. The compact system can hold and manipulate standard…

Read More

You might be interested in…Therapeutics Update

Dr. Ray O’Connor discusses the latest clinical studies on therapeutics, including the use of anabolic steroids which have serious adverse effects such as cardiovascular and psychiatric morbidity. A case-control study found an increase in mortality among AAS users compared to a control group. A trial on beta-blocker treatment post myocardial infarction with preserved ejection fraction…

Read More

Exclusive: Aktiia receives CE Mark for CALFREE optical blood pressure technology

Healthcare technology company Aktiia has received CE mark in Europe for its calibration-free technology CALFREE, which uses optical sensors in smartwatches and smartphone cameras to collect blood pressure data. This approval allows Aktiia to integrate its medical-grade optical blood pressure monitoring into third-party consumer devices, such as smartwatches and smartphones. Aktiia’s CEO believes this technology…

Read More

California Dabbles With Reining in Health Spending

California is attempting to control healthcare costs by setting spending caps, aiming to reduce growth to 3% by 2029. The state’s Office of Health Care Affordability is tasked with making care more affordable, accessible, and improving health outcomes. However, healthcare organizations are pushing back, arguing that the targets do not account for factors like an…

Read More

‘Urgent action’ needed to stem heart disease risk related to climate change

A review of nearly 500 observational studies found that environmental stressors exacerbated by climate change are linked to an increased risk of heart disease. The authors emphasized the urgent need for action to mitigate this trend. The studies analyzed the relationship between environmental exposures like extreme temperature, ground-level ozone, wildfire smoke, and extreme weather events…

Read More

One dead as mpox outbreak hits South Africa

An outbreak of mpox in South Africa has resulted in one death and four more individuals becoming infected. The Health Minister is working to secure more treatment drugs as a precaution. Mpox, a viral illness transmitted through contact with infected individuals or animals, causes painful lesions and other symptoms. The recent cases in South Africa…

Read More

Instron® Launches Next Generation Autoinjector Testing System

Instron has released a new Autoinjector Testing System for testing pen and autoinjectors to ISO 11608. This system, developed in partnership with pharmaceutical companies, measures essential performance requirements such as cap removal, dose accuracy, activation force, injection time, needle depth, and needle guard lockout. The system simplifies testing by allowing a complete sequence of tests…

Read More

‘Dramatic’ Phase 2 Results for Survodutide in MASH, Fibrosis

A new drug called Survodutide, which is a dual glucagon-like peptide 1 (GLP-1) and glucagon receptor agonist, has shown exceptional improvement in patients with metabolic dysfunction-associated steatohepatitis (MASH) based on phase 2 trial results. Up to 83% of patients on Survodutide experienced significant improvement in MASH compared to those on a placebo. Additionally, 75% of…

Read More

New treatment funded by Breakthrough Cancer Research

Breakthrough Cancer Research has provided €1 million in funding for a new treatment targeting inflammation in Barrett’s patients. The funding is also supported by industry and other charities like the Oesophageal Cancer Fund and Cross. Prof Jacintha O’Sullivan and PhD student Lorraine Smith announced the treatment, which aims to accelerate discoveries in the oesophageal cancer…

Read More

NeuroFlow acquires Owl to extend behavioral health offerings

Pennsylvania-based behavioral health company NeuroFlow has acquired Owl, a fellow behavioral digital health company, to expand its measurement-based offerings for providers. NeuroFlow offers a cloud-based platform for monitoring and connecting with patients, providing clinical decision support and personalized recommendations. Owl’s platform allows patients to report symptoms to providers before appointments, saving time and improving treatment…

Read More

Biden Plan to Save Medicare Patients Money on Drugs Risks Empty Shelves, Pharmacists Say

Within the new Biden administration policy to lower drug costs for Medicare patients, independent pharmacists are struggling to keep some prescription drugs in stock due to financial difficulties. The policy changes prescription prices for Medicare beneficiaries, adjusting them at the pharmacy counter, resulting in reduced overall costs for patients. However, this system means less money…

Read More

NIH ‘gain-of-function’ research needs more limits, say GOP lawmakers

Republican leaders in the House Energy and Commerce Committee are proposing a new oversight panel to regulate viral pathogen research, specifically gain-of-function studies. These studies involve making a virus more transmissible or virulent in a lab and have been deemed risky. The recommendation comes after a monthslong investigation into gain-of-function research conducted by the National…

Read More

Handedness in medicine: it makes sense to learn to use both sides

Adrian Drake-Lee, a retired ear, nose, and throat surgeon from Llanddona, UK, discusses the concept of laterality in medicine. He mentions that while medicine is often designed for right-handed people, there is more to consider beyond handedness. Drake-Lee personally experiences being right eye dominant despite having a strong left-handed preference. He also notes the importance…

Read More

Study demonstrates sustained reduction in child mortality following educational interventions in low-resourced countries

A study conducted by Mass General Brigham showed a significant reduction in the mortality rates of intubated pediatric patients in El Salvador after the implementation of a low-cost quality improvement program. The study focused on improving clinical practices in pediatric intensive care units in low and middle-income countries to reduce child mortality rates, which are…

Read More

UD researchers pioneer universal, economical method for proteomics sample preparation

Proteins play a vital role in biological functions, constantly changing as we age or face various health conditions. Monitoring these changes through proteomics can aid in drug discovery, disease diagnosis, and precision medicine. Yanbao Yu at the University of Delaware developed a simple, affordable method for preparing protein samples for analysis, leading to a patent-pending…

Read More

FDA OKs Sarilumab for Polyarticular JIA

The FDA approved sarilumab (Kevzara) for the treatment of polyarticular juvenile idiopathic arthritis (pJIA) for patients weighing ≥ 63 kg. It is estimated that nearly 300,000 children in the US have JIA, with 1 in 4 having pJIA. The drug, developed by Sanofi and Regeneron, is an interleukin 6 receptor blocker. Sarilumab was first approved…

Read More

Report: MA Beneficiaries Spend $2,500 Less on Healthcare Than Traditional Medicare Beneficiaries

A report conducted in 2021 by healthcare research firm ATI Advisory and commissioned by Better Medicare Alliance found that Medicare Advantage beneficiaries spent $2,541 less in out-of-pocket costs and premiums compared to fee-for-service Medicare beneficiaries. The study used data from the 2019 to 2021 Medicare Current Beneficiary Survey. The report also showed that Medicare Advantage…

Read More

NI consultants to strike later this month

Consultants in Northern Ireland plan to strike on June 26 due to ongoing pay dispute, with 92% voting in favor of industrial action. Their take-home pay has dropped by over 30% since 2008, in contrast to consultants in England and Ireland. The strike, if it proceeds, will impact routine and elective services but emergency cover…

Read More

Move For Migraine This June 15th

Migraine Canada is hosting its third annual Move for Migraine event in June to combat the stigma and support those affected by migraine in Canada. The event aims to raise awareness and reduce feelings of loneliness and isolation among individuals with migraine. Participants are encouraged to participate by skating, biking, or running to show support…

Read More

Chuck Divita named new Teladoc Health CEO

Teladoc Health has appointed Charles “Chuck” Divita III as its new CEO, coming from his role as executive vice president at GuideWell. Divita brings experience in handling large revenue and overseeing various functions. He has also served on the boards of other organizations and is a Certified Public Accountant. The company is confident in his…

Read More
Advertise here
error: Content is protected !!